CoChat
Sign Up
Cited by 308

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase

Bago, Ruzica, Malik, Nazma, Munson, Michael J., Prescott, Alan R., Davies, Paul, Sommer, Eeva, Shpiro, Natalia, Ward, Richard, Cross, Darren, Ganley, Ian G., Alessi, Dario R.·2014·Biochemical Journal
DOI 10.1042/bj20140889PMC PMC4209782
Open this paper in CoChat — free account

Abstract

The Vps34 (vacuolar protein sorting 34) class III PI3K (phosphoinositide 3-kinase) phosphorylates PtdIns (phosphatidylinositol) at endosomal membranes to generate PtdIns(3)P that regulates membrane trafficking processes via its ability to recruit a subset of proteins possessing PtdIns(3)P-binding PX (phox homology) and FYVE domains. In the present study, we describe a highly selective and potent inhibitor of Vps34, termed VPS34-IN1, that inhibits Vps34 with 25 nM IC50in vitro, but does not significantly inhibit the activity of 340 protein kinases or 25 lipid kinases tested that include all isoforms of class I as well as class II PI3Ks. Administration of VPS34-IN1 to cells induces a rapid dose-dependent dispersal of a specific PtdIns(3)P-binding probe from endosome membranes, within 1 min, without affecting the ability of class I PI3K to regulate Akt. Moreover, we explored whether SGK3 (serum- and glucocorticoid-regulated kinase-3), the only protein kinase known to interact specifically with PtdIns(3)P via its N-terminal PX domain, might be controlled by Vps34. Mutations disrupting PtdIns(3)P binding ablated SGK3 kinase activity by suppressing phosphorylation of the T-loop [PDK1 (phosphoinositide-dependent kinase 1) site] and hydrophobic motif (mammalian target of rapamycin site) residues. VPS34-IN1 induced a rapid ~50–60% loss of SGK3 phosphorylation within 1 min. VPS34-IN1 did not inhibit activity of the SGK2 isoform that does not possess a PtdIns(3)P-binding PX domain. Furthermore, class I PI3K inhibitors (GDC-0941 and BKM120) that do not inhibit Vps34 suppressed SGK3 activity by ~40%. Combining VPS34-IN1 and GDC-0941 reduced SGK3 activity ~80–90%. These data suggest SGK3 phosphorylation and hence activity is controlled by two pools of PtdIns(3)P. The first is produced through phosphorylation of PtdIns by Vps34 at the endosome. The second is due to the conversion of class I PI3K product, PtdIns(3,4,5)P3 into PtdIns(3)P, via the sequential actions of the PtdIns 5-phosphatases [SHIP1/2 (Src homology 2-domain-containing inositol phosphatase 1/2)] and PtdIns 4-phosphatase [INPP4B (inositol polyphosphate 4-phosphatase type II)]. VPS34-IN1 will be a useful probe to delineate physiological roles of the Vps34. Monitoring SGK3 phosphorylation and activity could be employed as a biomarker of Vps34 activity, in an analogous manner by which Akt is used to probe cellular class I PI3K activity. Combining class I (GDC-0941) and class III (VPS34-IN1) PI3K inhibitors could be used as a strategy to better analyse the roles and regulation of the elusive class II PI3K.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20140889

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. Kok, 2009, Regulation of phosphoinositide 3-kinase expression in health and disease, Trends Biochem Sci., 34, 115, 10.1016/j.tibs.2009.01.003 · DOI
  2. Raiborg, 2013, Class III phosphatidylinositol 3-kinase and its catalytic product PtdIns3P in regulation of endocytic membrane traffic, FEBS J., 280, 2730, 10.1111/febs.12116 · DOI
  3. Workman, 2010, Drugging the PI3 kinome: from chemical tools to drugs in the clinic, Cancer Res., 70, 2146, 10.1158/0008-5472.CAN-09-4355 · DOI
  4. Bartholomeusz, 2012, Targeting the PI3K signaling pathway in cancer therapy, Expert Opin. Ther. Targets, 16, 121, 10.1517/14728222.2011.644788 · DOI
  5. Vanhaesebroeck, 2010, The emerging mechanisms of isoform-specific PI3K signalling, Nat. Rev. Mol. Cell Biol., 11, 329, 10.1038/nrm2882 · DOI · Paper page
  6. Vanhaesebroeck, 2012, PI3K signalling: the path to discovery and understanding, Nat. Rev. Mol. Cell Biol., 13, 195, 10.1038/nrm3290 · DOI
  7. Lemmon, 2000, Signal-dependent membrane targeting by pleckstrin homology (PH) domains, Biochem. J., 350, 1, 10.1042/0264-6021:3500001 · DOI
  8. Hers, 2011, Akt signalling in health and disease, Cell. Signal., 23, 1515, 10.1016/j.cellsig.2011.05.004 · DOI
  9. Alessi, 1997, 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase, Curr. Biol., 7, 776, 10.1016/S0960-9822(06)00336-8 · DOI
  10. Alessi, 1997, Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα, Curr. Biol., 7, 261, 10.1016/S0960-9822(06)00122-9 · DOI
  11. Stephens, 1998, Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B, Science, 279, 710, 10.1126/science.279.5351.710 · DOI
  12. Stokoe, 1997, Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B, Science, 277, 567, 10.1126/science.277.5325.567 · DOI
  13. Najafov, 2012, Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors, Biochem. J., 448, 285, 10.1042/BJ20121287 · DOI
  14. Ooms, 2009, The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease, Biochem. J., 419, 29, 10.1042/BJ20081673 · DOI
  15. Agoulnik, 2011, INPP4B: the new kid on the PI3K block, Oncotarget, 2, 321, 10.18632/oncotarget.260 · DOI
  16. Amoasii, 2012, Myotubularin phosphoinositide phosphatases in human diseases, Curr. Top. Microbiol. Immunol., 362, 209
  17. Traer, 2006, Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?, Bull. Cancer, 93, E53
  18. Foster, 2003, The phosphoinositide (PI) 3-kinase family, J. Cell Sci., 116, 3037, 10.1242/jcs.00609 · DOI
  19. Schu, 1993, Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting, Science, 260, 88, 10.1126/science.8385367 · DOI · Paper page
  20. Stack, 1993, A membrane-associated complex containing the Vps15 protein kinase and the Vps34 PI 3-kinase is essential for protein sorting to the yeast lysosome-like vacuole, EMBO J., 12, 2195, 10.1002/j.1460-2075.1993.tb05867.x · DOI
  21. Funderburk, 2010, The Beclin 1–VPS34 complex: at the crossroads of autophagy and beyond, Trends Cell Biol., 20, 355, 10.1016/j.tcb.2010.03.002 · DOI
  22. Backer, 2008, The regulation and function of Class III PI3Ks: novel roles for Vps34, Biochem. J., 410, 1, 10.1042/BJ20071427 · DOI
  23. Simonsen, 2009, Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes, J. Cell Biol., 186, 773, 10.1083/jcb.200907014 · DOI
  24. Lemmon, 2008, Membrane recognition by phospholipid-binding domains, Nat. Rev. Mol. Cell Biol., 9, 99, 10.1038/nrm2328 · DOI · Paper page
  25. Lemmon, 2003, Phosphoinositide recognition domains, Traffic, 4, 201, 10.1034/j.1600-0854.2004.00071.x · DOI
  26. Ellson, 2002, The PX domain: a new phosphoinositide-binding module, J. Cell Sci., 115, 1099, 10.1242/jcs.115.6.1099 · DOI
  27. Gillooly, 2000, Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells, EMBO J., 19, 4577, 10.1093/emboj/19.17.4577 · DOI · Paper page
  28. Simonsen, 2001, The role of phosphoinositides in membrane transport, Curr. Opin. Cell Biol., 13, 485, 10.1016/S0955-0674(00)00240-4 · DOI · Paper page
  29. Dowler, 2002, Protein lipid overlay assay, Sci STKE., 2002, pl6, 10.1126/stke.2002.129.pl6 · DOI
  30. Folkes, 2008, The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-t hieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer, J. Med. Chem., 51, 5522, 10.1021/jm800295d · DOI
  31. Virbasius, 2001, Activation of the Akt-related cytokine-independent survival kinase requires interaction of its phox domain with endosomal phosphatidylinositol 3-phosphate, Proc. Natl. Acad. Sci. U.S.A., 98, 12908, 10.1073/pnas.221352898 · DOI
  32. Xing, 2004, Structural basis of membrane targeting by the Phox homology domain of cytokine-independent survival kinase (CISK-PX), J. Biol. Chem., 279, 30662, 10.1074/jbc.M404107200 · DOI
  33. Simonsen, 1998, EEA1 links PI(3)K function to Rab5 regulation of endosome fusion, Nature, 394, 494, 10.1038/28879 · DOI · Paper page
  34. Kobayashi, 1999, Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase, Biochem. J., 344, 189, 10.1042/0264-6021:3440189 · DOI · Paper page
  35. Garcia-Martinez, 2008, mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1), Biochem. J., 416, 375, 10.1042/BJ20081668 · DOI · Paper page
  36. Biondi, 2001, The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB, EMBO J., 20, 4380, 10.1093/emboj/20.16.4380 · DOI · Paper page
  37. Collins, 2005, In vivo role of the phosphate groove of PDK1 defined by knockin mutation, J. Cell Sci., 118, 5023, 10.1242/jcs.02617 · DOI
  38. Najafov, 2011, Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1, Biochem. J., 433, 357, 10.1042/BJ20101732 · DOI
  39. Maira, 2012, Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor, Mol. Cancer Ther., 11, 317, 10.1158/1535-7163.MCT-11-0474 · DOI
  40. Chresta, 2010, AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity, Cancer Res., 70, 288, 10.1158/0008-5472.CAN-09-1751 · DOI · Paper page
  41. Sommer, 2013, Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors, Biochem. J., 452, 499, 10.1042/BJ20130342 · DOI
  42. Petiot, 2000, Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells, J. Biol. Chem., 275, 992, 10.1074/jbc.275.2.992 · DOI
  43. Schink, 2013, Phosphatidylinositol 3-phosphate, a lipid that regulates membrane dynamics, protein sorting and cell signalling, BioEssays, 35, 900, 10.1002/bies.201300064 · DOI
  44. Li, 2010, The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt, Mol. Cancer Ther., 9, 113, 10.1158/1535-7163.MCT-08-1189 · DOI
  45. Choji, 1992, Alveolar hydatid disease of the liver: computed tomography and transabdominal ultrasound with histopathological correlation, Clin. Radiol., 46, 97, 10.1016/S0009-9260(05)80311-3 · DOI
  46. Ferby, 1996, PAF-induced MAPK activation is inhibited by wortmannin in neutrophils and macrophages, Adv. Exp. Med. Biol., 416, 321, 10.1007/978-1-4899-0179-8 · DOI
  47. Gharbi, 2007, Exploring the specificity of the PI3K family inhibitor LY294002, Biochem. J., 404, 15, 10.1042/BJ20061489 · DOI
  48. Futter, 2001, Human VPS34 is required for internal vesicle formation within multivesicular endosomes, J. Cell Biol., 155, 1251, 10.1083/jcb.200108152 · DOI
  49. Pelkmans, 2004, Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic, Cell, 118, 767, 10.1016/j.cell.2004.09.003 · DOI
  50. Bergeland, 2008, Cell-cycle-dependent binding kinetics for the early endosomal tethering factor EEA1, EMBO Rep., 9, 171, 10.1038/sj.embor.7401152 · DOI
  51. Liu, 2000, Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival, Curr. Biol., 10, 1233, 10.1016/S0960-9822(00)00733-8 · DOI
  52. Calleja, 2007, Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo, PLoS Biol., 5, e95, 10.1371/journal.pbio.0050095 · DOI
  53. Calleja, 2009, Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition, PLoS Biol., 7, e17, 10.1371/journal.pbio.1000017 · DOI
  54. Devereaux, 2013, Regulation of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis, PLoS ONE, 8, e76405, 10.1371/journal.pone.0076405 · DOI · Paper page
  55. Yoshioka, 2012, Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function, Nat. Med., 18, 1560, 10.1038/nm.2928 · DOI
  56. Krag, 2010, PI3KC2α, a class II PI3K, is required for dynamin-independent internalization pathways, J. Cell Sci., 123, 4240, 10.1242/jcs.071712 · DOI
  57. Vasudevan, 2009, AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer, Cancer Cell, 16, 21, 10.1016/j.ccr.2009.04.012 · DOI
  58. Wang, 2011, SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells, Mol. Endocrinol., 25, 72, 10.1210/me.2010-0294 · DOI
  59. Liu, 2012, Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma, Hepatology, 55, 1754, 10.1002/hep.25584 · DOI
  60. Xu, 2012, SGK3 is associated with estrogen receptor expression in breast cancer, Breast Cancer Res. Treat, 134, 531, 10.1007/s10549-012-2081-x · DOI
  61. Bruhn, 2013, AKT-independent PI3-K signaling in cancer: emerging role for SGK3, Cancer Manag. Res., 5, 281

Cited by

Sorted by citations

Metadata

Authors
Bago, R., Malik, N., Munson, M. J., Prescott, A. R., Davies, P., Sommer, E., Shpiro, N., Ward, R., Cross, D., Ganley, I. G., & Alessi, D. R.
Venue
Biochemical Journal
Publisher
Portland Press Ltd.
Published
2014-10-10
Volume
463
Issue
3
Pages
413-427
ISSN
  • 0264-6021
  • 1470-8728
DOI
10.1042/bj20140889
PMC
PMC4209782
Cited by
308
References
7
Language
en
Licence
creativecommons.org/licenses/by/3.0/ (vor, 1749 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review